Investigation of Frequent PVCs in Ventricular Trigeminy
Begin with a 12-lead ECG to characterize PVC morphology, followed by echocardiography to assess left ventricular function and exclude structural heart disease, then obtain ambulatory monitoring to quantify PVC burden 1, 2.
Initial Diagnostic Workup
History and Physical Examination
Focus on specific high-yield elements rather than generic assessment 1:
Symptom Assessment:
- Palpitations, dyspnea, presyncope, fatigue, or syncope (particularly exertional syncope which demands urgent evaluation)
- Note that trigeminy creates effective bradycardia with apical-radial pulse deficit and relative hypertension with wide pulse pressure 1
- Many patients are completely asymptomatic, discovered incidentally 2
Critical Historical Red Flags 1:
- Family history of sudden cardiac death, sudden cardiac arrest, unexplained drowning, or SIDS in first-degree relatives
- Personal history of ischemic heart disease, cardiomyopathy, or cardiac channelopathies
- Medication use causing QT prolongation (check www.crediblemeds.org) or Brugada pattern (www.brugadadrugs.org)
- Thyroid disease, electrolyte abnormalities, kidney disease
- Alcohol or illicit drug use
Physical Examination Targets 1:
- Carotid bruits or diminished peripheral pulses (atherosclerotic disease)
- Jugular venous distention, rales, gallops, peripheral edema (heart failure)
- Cardiac murmurs (aortic stenosis, mitral regurgitation)
- Midsystolic click (mitral valve prolapse associated with ventricular arrhythmias)
Electrocardiographic Evaluation
- Determine PVC morphology (left bundle branch block vs. right bundle branch block pattern)
- Localize site of origin based on QRS axis and morphology
- Assess for underlying structural disease markers (Q waves, left ventricular hypertrophy, QT prolongation)
Echocardiography
Echocardiography is mandatory in the presence of symptoms or frequent PVCs 2:
- Assess left ventricular ejection fraction (LVEF)
- Exclude structural heart disease (cardiomyopathies, valvular disease, wall motion abnormalities)
- Look for regional wall motion abnormalities suggesting ischemic disease
Ambulatory Monitoring
24-hour Holter or extended ambulatory monitoring 2:
- Quantify PVC burden (percentage of total beats)
- Critical threshold: PVC burden ≥10% raises concern for PVC-induced cardiomyopathy 4
- Higher risk threshold: PVC burden >20% warrants consideration of ablation even if asymptomatic 4
- Document symptom-rhythm correlation
Advanced Imaging
Cardiac MRI should be performed if 4, 5:
- ECG and echocardiography do not clearly exclude structural heart disease
- Clinical presentation raises suspicion for structural disease
- Unexplained LVEF dysfunction with PVC burden ≥10%
- Late gadolinium enhancement identifies arrhythmia substrate even with normal LV function 5
Risk Stratification Algorithm
High-Risk Features Requiring Aggressive Investigation:
- Syncope (especially exertional) 1
- Reduced LVEF or heart failure symptoms 2
- PVC burden ≥10% with any LVEF reduction 4
- Family history of sudden cardiac death 1
- Structural heart disease on imaging 4
Moderate-Risk Features:
- PVC burden >20% with normal LVEF 4
- Significant symptoms (palpitations, dyspnea, fatigue) 2
- Multiple PVC morphologies suggesting different origins
Lower-Risk Features:
- Asymptomatic or mildly symptomatic
- PVC burden <10%
- Normal LVEF and no structural heart disease
- Benign PVC morphology (right ventricular outflow tract pattern) 6
Common Pitfalls
Do not assume trigeminy is benign simply because the patient is asymptomatic—PVC-induced cardiomyopathy can develop silently 4, 7. The effective bradycardia from trigeminy can also lead to inaccurate heart rate estimation 1.
Do not skip cardiac MRI when echocardiography is equivocal or shows unexplained dysfunction—late gadolinium enhancement provides critical substrate information 5.
Do not rely solely on symptom burden to guide investigation intensity—frequent PVCs (>10-20% burden) warrant thorough evaluation regardless of symptoms due to cardiomyopathy risk 4, 7.